Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545-552; doi:10.1124/jpet.105.087643.
出版信息
J Pharmacol Exp Ther. 2014 Mar;348(3):493. doi: 10.1124/jpet.114.03er14b.
PMID:24534945
Abstract
摘要
相似文献
1
Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545-552; doi:10.1124/jpet.105.087643.
J Pharmacol Exp Ther. 2014 Mar;348(3):493. doi: 10.1124/jpet.114.03er14b.
2
Re: Kobuchi S, Tanaka R, Shintani T, Suzuki R, Tsutsui H, Ohkita M, Ayajiki K, and Matsumura Y (2011) mechanisms underlying the renoprotective effect of GABA against ischemia/reperfusion-induced renal injury in rats. J Pharmacol Exp Ther 338:767-774; doi:10.1124/jpet.111.180174.
J Pharmacol Exp Ther. 2014 May;349(2):347. doi: 10.1124/jpet.114.05er14c.
3
Re: Ueda K, Tsuju F, Hirata T, Ueda K, Murai M, Aono H, Takaoka M, and Matsumura Y (2009) preventive effect of SA13353 [1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea], a novel transient receptor potential vanilloid 1 agonist, on ischemia/reperfusion-induced renal injury in rats. J Pharmacol Exp Ther 329:202-209; doi:10.1124/jpet.108.146241.回复：上田K、辻司F、平田T、上田K、村井M、青野H、高冈M和松村Y（2009年）新型瞬时受体电位香草酸亚型1激动剂SA13353 [1-[2-(1-金刚烷基)乙基]-1-戊基-3-[3-(4-吡啶基)丙基]脲]对大鼠缺血/再灌注诱导的肾损伤的预防作用。《药理学与实验治疗学杂志》329:202 - 209；doi:10.1124/jpet.108.146241
J Pharmacol Exp Ther. 2014 May;349(2):346. doi: 10.1124/jpet.114.05er14b.
4
Re: Magierowski M, Jasnos K, Pawlik M, Krzysiek-Maczka G, Ptak-Belowska A, Olszanecki R, Kwiecien S, Korbut R, and Brzozowski T (2013) Role of Angiotensin-(1-7) in Gastroprotection against Stress-Induced Ulcerogenesis. The Involvement of Mas Receptor, Nitric Oxide, Prostaglandins, and Sensory Neuropeptides. J Pharmacol Exp Ther 347:717-726; doi:10.1124/jpet.113.207233.
J Pharmacol Exp Ther. 2015 Jun;353(3):563. doi: 10.1124/jpet.115.06er15.
5
Re: Nakajima A, Ueda K, Takaoka M, Yoshimi Y, and Matsumura Y (2006) opposite effects of pre- and postischemic treatments with nitric oxide donor on ischemia/reperfusion-induced renal injury. J Pharmacol Exp Ther 316:1038-1046; doi:10.1124/jpet.105.092049.
J Pharmacol Exp Ther. 2014 May;349(2):345. doi: 10.1124/jpet.114.05er14a.
6
Re: Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schönfeld P, Roessner A, and Gali-Muhtasib H (2005) 5-aza-Cytidine Is a Potent Inhibitor of DNA Methyltransferase 3a and Induces Apoptosis in HCT-116 Colon Cancer Cells via Gadd45- and p53-Dependent Mechanisms. J Pharmacol Exp Ther February 2005 312:525-536; doi:10.1124/jpet.104.074195.回复：施奈德 - 斯托克R、迪亚布 - 阿塞夫M、罗尔贝克A、福尔策 - 朱尔丹内C、博尔策C、哈蒂格R、舍恩菲尔德P、罗斯纳A和加利 - 穆塔西卜H（2005年）。5 - 氮杂胞苷是DNA甲基转移酶3a的强效抑制剂，并通过Gadd45和p53依赖机制诱导HCT - 116结肠癌细胞凋亡。《药理学与实验治疗学杂志》2005年2月，第312卷：525 - 536页；doi:10.1124/jpet.104.074195 。
J Pharmacol Exp Ther. 2016 Oct;359(1):90. doi: 10.1124/jpet.113.074195retraction.
7
Notice of Retraction: Harada S, Yamazaki Y, and Tokuyama S (2013) Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor, , 344: 276-285; DOI: https://doi.org/10.1124/jpet.112.199604.撤稿通知：原田S、山崎Y和德山S（2013年）《食欲素A通过下丘脑源性神经营养因子抑制缺血后葡萄糖不耐受和神经元损伤》，《药理学与实验治疗学杂志》，344：276 - 285；DOI：https://doi.org/10.1124/jpet.112.199604 。
J Pharmacol Exp Ther. 2020 Nov;375(2):397. doi: 10.1124/jpet.112.199604retraction.
8
Re: Kadam RS and Kompella UB (2010) Influence of Lipophilicity on Drug Partitioning into Sclera, Choroid-Retinal Pigment Epithelium, Retina, Trabecular Meshwork, and Optic Nerve. J Pharmacol Exp Ther 332:1107-1120; doi:10.1124/jpet.109.161570.回复：卡丹姆·R·S和孔佩拉·U·B（2010年）亲脂性对药物在巩膜、脉络膜-视网膜色素上皮、视网膜、小梁网和视神经中分配的影响。《药理学与实验治疗学杂志》332卷：1107 - 1120页；doi:10.1124/jpet.109.161570
J Pharmacol Exp Ther. 2015 Feb;352(2):326. doi: 10.1124/jpet.114.02er15.
9
Re: Norman AB, Tabet MR, Norman MK, and Tsibulsky VL (2014) Maintained Cocaine Self-Administration Is Determined by Quantal Responses: Implications for the Measurement of Antagonist Potency. J Pharmacol Exp Ther 348:311-315; doi:10.1124/jpet.113.210690.回复：诺曼·AB、塔贝特·MR、诺曼·MK和齐布尔斯基·VL（2014年）。持续的可卡因自我给药由量子反应决定：对拮抗剂效力测量的启示。《药理学与实验治疗学杂志》348：311 - 315；doi:10.1124/jpet.113.210690
J Pharmacol Exp Ther. 2016 Aug;358(2):241. doi: 10.1124/jpet.113.210690retraction.
10
Notice of Concern: McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, and Harding JW (2013) Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents, , 344: 141-154; DOI: https://doi.org/10.1124/jpet.112.199497.关注通知：麦科伊·AT、贝努瓦·CC、赖特·JW、卡瓦斯·LH、布勒-戈加雷·JM、朱·M、阿普利亚德·SM、韦曼·GA和哈丁·JW（2013年）。代谢稳定的血管紧张素IV类似物作为促认知/抗痴呆药物的评估，《药理学与实验治疗学杂志》，344: 141 - 154；DOI: https://doi.org/10.1124/jpet.112.199497 。
J Pharmacol Exp Ther. 2021 Sep;378(3):313. doi: 10.1124/jpet.112.199497concern.
Zotero 插件